Germinal center output is sustained by HELLS-dependent DNA-methylation-maintenance in B cells
© 2023. Springer Nature Limited..
HELLS/LSH (Helicase, Lymphoid Specific) is a SNF2-like chromatin remodelling protein involved in DNA methylation. Its loss-of-function in humans causes humoral immunodeficiency, called ICF4 syndrome (Immunodeficiency, Centromeric Instability, Facial anomalies). Here we show by our newly generated B-cell-specific Hells conditional knockout mouse model that HELLS plays a pivotal role in T-dependent B-cell responses. HELLS deficiency induces accelerated decay of germinal center (GC) B cells and impairs the generation of high affinity memory B cells and circulating antibodies. Mutant GC B cells undergo dramatic DNA hypomethylation and massive de-repression of evolutionary recent retrotransposons, which surprisingly does not directly affect their survival. Instead, they prematurely upregulate either memory B cell markers or the transcription factor ATF4, which is driving an mTORC1-dependent metabolic program typical of plasma cells. Treatment of wild type mice with a DNMT1-specific inhibitor phenocopies the accelerated kinetics, thus pointing towards DNA-methylation maintenance by HELLS being a crucial mechanism to fine-tune the GC transcriptional program and enable long-lasting humoral immunity.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
---|---|
Enthalten in: |
Nature communications - 14(2023), 1 vom: 14. Sept., Seite 5695 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Cousu, Clara [VerfasserIn] |
---|
Links: |
---|
Themen: |
9007-49-2 |
---|
Anmerkungen: |
Date Completed 20.09.2023 Date Revised 12.02.2024 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s41467-023-41317-3 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM362069794 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM362069794 | ||
003 | DE-627 | ||
005 | 20240212231917.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41467-023-41317-3 |2 doi | |
028 | 5 | 2 | |a pubmed24n1289.xml |
035 | |a (DE-627)NLM362069794 | ||
035 | |a (NLM)37709749 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Cousu, Clara |e verfasserin |4 aut | |
245 | 1 | 0 | |a Germinal center output is sustained by HELLS-dependent DNA-methylation-maintenance in B cells |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 20.09.2023 | ||
500 | |a Date Revised 12.02.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. Springer Nature Limited. | ||
520 | |a HELLS/LSH (Helicase, Lymphoid Specific) is a SNF2-like chromatin remodelling protein involved in DNA methylation. Its loss-of-function in humans causes humoral immunodeficiency, called ICF4 syndrome (Immunodeficiency, Centromeric Instability, Facial anomalies). Here we show by our newly generated B-cell-specific Hells conditional knockout mouse model that HELLS plays a pivotal role in T-dependent B-cell responses. HELLS deficiency induces accelerated decay of germinal center (GC) B cells and impairs the generation of high affinity memory B cells and circulating antibodies. Mutant GC B cells undergo dramatic DNA hypomethylation and massive de-repression of evolutionary recent retrotransposons, which surprisingly does not directly affect their survival. Instead, they prematurely upregulate either memory B cell markers or the transcription factor ATF4, which is driving an mTORC1-dependent metabolic program typical of plasma cells. Treatment of wild type mice with a DNMT1-specific inhibitor phenocopies the accelerated kinetics, thus pointing towards DNA-methylation maintenance by HELLS being a crucial mechanism to fine-tune the GC transcriptional program and enable long-lasting humoral immunity | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a DNA |2 NLM | |
650 | 7 | |a 9007-49-2 |2 NLM | |
650 | 7 | |a DNA Helicases |2 NLM | |
650 | 7 | |a EC 3.6.4.- |2 NLM | |
650 | 7 | |a HELLS protein, human |2 NLM | |
650 | 7 | |a EC 5.99.- |2 NLM | |
650 | 7 | |a Hells protein, mouse |2 NLM | |
650 | 7 | |a EC 5.99.- |2 NLM | |
700 | 1 | |a Mulot, Eléonore |e verfasserin |4 aut | |
700 | 1 | |a De Smet, Annie |e verfasserin |4 aut | |
700 | 1 | |a Formichetti, Sara |e verfasserin |4 aut | |
700 | 1 | |a Lecoeuche, Damiana |e verfasserin |4 aut | |
700 | 1 | |a Ren, Jianke |e verfasserin |4 aut | |
700 | 1 | |a Muegge, Kathrin |e verfasserin |4 aut | |
700 | 1 | |a Boulard, Matthieu |e verfasserin |4 aut | |
700 | 1 | |a Weill, Jean-Claude |e verfasserin |4 aut | |
700 | 1 | |a Reynaud, Claude-Agnès |e verfasserin |4 aut | |
700 | 1 | |a Storck, Sébastien |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nature communications |d 2010 |g 14(2023), 1 vom: 14. Sept., Seite 5695 |w (DE-627)NLM199274525 |x 2041-1723 |7 nnns |
773 | 1 | 8 | |g volume:14 |g year:2023 |g number:1 |g day:14 |g month:09 |g pages:5695 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41467-023-41317-3 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 14 |j 2023 |e 1 |b 14 |c 09 |h 5695 |